Skip to Main Content
Access your saved content
Accenture’s extensive regulatory knowledge and experience helps life sciences companies manage, compile, quality-check, publish and maintain global standards-enabled submissions.
Accenture assists clients with global submission strategy and management. We combine deep regulatory operations, regulatory affairs and regulatory intelligence knowledge with advanced technology and standards-based processes to deliver measurable results.
By incorporating industry standards and best practices in our regulatory services delivery, Accenture enables our clients to gain powerful benefits across the entire clinical information and regulatory submission process. We provide comprehensive support for electronic, paper, hybrid, and eCTD submissions, including eCTD services for NDAs, BLAs and supplements, MAAs, INDs, and NDS applications.
Accenture Accelerated R&D Services delivers digitally enabled technologies and services across the clinical, regulatory and pharmacovigilance functions around the globe. This business service allows pharmaceutical companies to bring drugs to market faster, at less cost and with reduced execution risks.
Accenture Accelerated R&D Services can help our clients:
We work with industry-leading Life Sciences companies in more than 50 countries, as well as more than 125 public health organizations. We have more than 20 years of global delivery experience.
Through a broad array of consulting services for regulatory affairs and operations, Accenture supports all aspects of global submission management. Our service offerings are joined with advanced technology to offer flexible solutions that address functional needs and augment in-house capabilities. Additional services include:
Skip Footer Links